|
1
|
Odorico JS, Kaufman DS and Thomson JA:
Multilineage differentiation from human embryonic stem cell lines.
Stem Cells. 19:193–204. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Romano G: The role of adult stem cells in
carcinogenesis. Drug News Perspect. 18:555–559. 2005. View Article : Google Scholar
|
|
3
|
Clarke MF, Dick JE, Dirks PB, et al:
Cancer stem cells - perspectives on current status and future
directions: AACR Workshop on cancer stem cells. Cancer Res.
66:9339–9344. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo W, Lasky JL and Wu H: Cancer stem
cells. Pediatr Res. 59:59R–64R. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: Models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar
|
|
6
|
Gibbs CP, Kukekov VG, Reith JD, et al:
Stem-like cells in bone sarcomas: Implications for tumorigenesis.
Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wilson H, Huelsmeyer M, Chun R, Young KM,
Friedrichs K and Argyle DJ: Isolation and characterisation of
cancer stem cells from canine osteosarcoma. Vet J. 175:69–75. 2008.
View Article : Google Scholar
|
|
8
|
Bhat-Nakshatri P, Appaiah H, Ballas C, et
al: SLUG/SNAI2 and tumor necrosis factor generate breast cells with
CD44+/CD24− phenotype. BMC Cancer.
10:4112010. View Article : Google Scholar
|
|
9
|
Sheridan C, Kishimoto H, Fuchs RK, et al:
CD44+/CD24− breast cancer cells exhibit
enhanced invasive properties: an early step necessary for
metastasis. Breast Cancer Res. 8:R592006. View Article : Google Scholar
|
|
10
|
DeSantis C, Siegel R, Bandi P and Jemal A:
Breast cancer statistics, 2011. CA Cancer J Clin. 61:409–418. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ponti D, Costa A, Zaffaroni N, et al:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Donnenberg VS and Donnenberg AD: Multiple
drug resistance in cancer revisited: The cancer stem cell
hypothesis. J Clin Pharmacol. 45:872–877. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Campbell PA, Perez-Iratxeta C,
Andrade-Navarro MA and Rudnicki MA: Oct4 targets regulatory nodes
to modulate stem cell function. PLoS One. 2:e5532007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tai MH, Chang CC, Kiupel M, Webster JD,
Olson LK and Trosko JE: Oct4 expression in adult human stem cells:
evidence in support of the stem cell theory of carcinogenesis.
Carcinogenesis. 26:495–502. 2005. View Article : Google Scholar
|
|
17
|
Mitsui K, Tokuzawa Y, Itoh H, et al: The
homeoprotein Nanog is required for maintenance of pluripotency in
mouse epiblast and ES cells. Cell. 113:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jeter CR, Badeaux M, Choy G, et al:
Functional evidence that the self-renewal gene NANOG regulates
human tumor development. Stem Cells. 27:993–1005. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL
and Wu CL: Oct-3/4 expression reflects tumor progression and
regulates motility of bladder cancer cells. Cancer Res.
68:6281–6291. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Velkey JM and O’Shea KS: Oct4 RNA
interference induces trophectoderm differentiation in mouse
embryonic stem cells. Genesis. 37:18–24. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gidekel S, Pizov G, Bergman Y and Pikarsky
E: Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer
Cell. 4:361–370. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boyer LA, Lee TI, Cole MF, et al: Core
transcriptional regulatory circuitry in human embryonic stem cells.
Cell. 122:947–956. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ezeh UI, Turek PJ, Reijo RA and Clark AT:
Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are
expressed in both seminoma and breast carcinoma. Cancer.
104:2255–2265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu C, Lu Y, Wang B, et al: Clinical
implications of stem cell gene Oct-4 expression in breast cancer.
Ann Surg. 253:1165–1171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dontu G, Abdallah WM, Foley JM, et al: In
vitro propagation and transcriptional profiling of human mammary
stem/progenitor cells. Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dontu G and Wicha MS: Survival of mammary
stem cells in suspension culture: Implications for stem cell
biology and neoplasia. J Mammary Gland Biol Neoplasia. 10:75–86.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li HZ, Yi TB and Wu ZY: Suspension culture
combined with anticancer regimens for screening breast cancer stem
cells. Med Hypotheses. 68:988–990. 2007. View Article : Google Scholar
|
|
28
|
Sell S: Stem cell origin of cancer and
differentiation therapy. Crit Rev Oncol Hematol. 51:1–28. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abraham BK, Fritz P, McClellan M,
Hauptvogel P, Athelogou M and Brauch H: Prevalence of
CD44+/CD24−/low cells in breast cancer may
not be associated with clinical outcome but may favor distant
metastasis. Clin Cancer Res. 11:1154–1159. 2005.PubMed/NCBI
|
|
30
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schinkel AH and Jonker JW: Mammalian drug
efflux transporters of the ATP binding cassette (ABC) family: an
overview. Adv Drug Deliv Rev. 55:3–29. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Szakács G, Annereau JP, Lababidi S, et al:
Predicting drug sensitivity and resistance: profiling ABC
transporter genes in cancer cells. Cancer Cell. 6:129–137. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gottesman MM, Ludwig J, Xia D and Szakács
G: Defeating drug resistance in cancer. Discov Med. 6:18–23.
2006.
|
|
34
|
Ji J, Werbowetski-Ogilvie TE, Zhong B,
Hong SH and Bhatia M: Pluripotent transcription factors possess
distinct roles in normal versus transformed human stem cells. PLoS
One. 4:e80652009. View Article : Google Scholar : PubMed/NCBI
|
